company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
PharMerica Corp,PMC,,0001388195,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 16:01:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,450500000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 16:01:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,450500000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 16:01:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,392900000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 16:01:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,392900000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 16:01:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,57600000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 16:01:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,43000000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 16:01:58+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2400000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 16:01:58+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,9200000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 16:01:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,54600000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 16:01:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3000000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 16:01:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,800000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 16:01:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-800000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 16:01:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2200000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 16:01:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,900000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 16:01:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1300000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 16:01:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1300000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 16:01:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1300000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 16:01:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30421549.0
PharMerica Corp,PMC,,0001388195,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 16:01:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
PharMerica Corp,PMC,,0001388195,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 16:01:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30605727.0
PharMerica Corp,PMC,,0001388195,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 16:01:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.04
PharMerica Corp,PMC,,0001388195,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 16:01:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32500000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q2,2010-04-01,2010-06-30,2011-08-04 16:01:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
PharMerica Corp,PMC,,0001388195,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:01:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,443100000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:01:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,443100000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:01:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,386300000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:01:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,386300000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:01:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,56800000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:01:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,43300000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:01:55+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2200000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:01:55+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2400000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:01:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47900000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:01:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8900000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:01:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,900000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:01:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-900000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:01:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8000000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:01:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3200000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:01:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4800000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:01:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4800000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:01:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4800000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:01:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30033618.0
PharMerica Corp,PMC,,0001388195,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:01:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.16
PharMerica Corp,PMC,,0001388195,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:01:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30122302.0
PharMerica Corp,PMC,,0001388195,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:01:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.16
PharMerica Corp,PMC,,0001388195,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:01:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30000000.0
PharMerica Corp,PMC,,0001388195,2010.0,Q3,2010-07-01,2010-09-30,2011-11-03 16:01:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.16
PharMerica Corp,PMC,,0001388195,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:01:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,535100000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:01:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,535100000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:01:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,469000000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:01:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,469000000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:01:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,66100000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:01:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,52000000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:01:48+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2700000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:01:48+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,4700000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:01:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59400000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:01:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6700000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:01:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1100000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:01:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1100000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:01:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5600000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:01:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2300000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:01:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3300000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:01:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3300000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:01:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3300000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:01:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29272481.0
PharMerica Corp,PMC,,0001388195,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:01:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.11
PharMerica Corp,PMC,,0001388195,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:01:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29362134.0
PharMerica Corp,PMC,,0001388195,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:01:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
PharMerica Corp,PMC,,0001388195,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:01:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30000000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q1,2011-01-01,2011-03-31,2012-05-02 16:01:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.11
PharMerica Corp,PMC,,0001388195,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:01:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,531700000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:01:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,531700000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:01:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,454700000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:01:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,454700000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:01:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,77000000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:01:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,55700000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:01:55+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2700000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:01:55+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,5100000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:01:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,63500000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:01:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13500000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:01:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2600000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:01:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2600000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:01:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10900000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:01:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3500000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:01:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7400000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:01:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7400000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:01:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7400000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:01:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29331854.0
PharMerica Corp,PMC,,0001388195,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:01:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.25
PharMerica Corp,PMC,,0001388195,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:01:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29437422.0
PharMerica Corp,PMC,,0001388195,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:01:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.25
PharMerica Corp,PMC,,0001388195,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:01:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29600000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q2,2011-04-01,2011-06-30,2012-08-02 16:01:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.25
PharMerica Corp,PMC,,0001388195,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:02:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,518700000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:02:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,518700000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:02:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,443000000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:02:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,443000000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:02:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,75700000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:02:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,55100000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:02:58+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3000000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:02:58+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1800000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:02:58+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,5100000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:02:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,65000000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:02:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10700000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:02:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2600000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:02:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2600000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:02:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8100000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:02:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3300000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:02:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4800000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:02:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4800000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:02:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4800000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:02:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29366998.0
PharMerica Corp,PMC,,0001388195,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:02:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.16
PharMerica Corp,PMC,,0001388195,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:02:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29531095.0
PharMerica Corp,PMC,,0001388195,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:02:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.16
PharMerica Corp,PMC,,0001388195,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:02:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30000000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q3,2011-07-01,2011-09-30,2012-11-01 16:02:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.16
PharMerica Corp,PMC,,0001388195,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,495600000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,495600000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,419500000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,419500000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,76100000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,53700000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2600000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,3700000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,60000000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,16100000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2500000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2500000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13600000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5700000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7900000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7900000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7900000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29343221.0
PharMerica Corp,PMC,,0001388195,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.28
PharMerica Corp,PMC,,0001388195,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29468452.0
PharMerica Corp,PMC,,0001388195,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.27
PharMerica Corp,PMC,,0001388195,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29300000.0
PharMerica Corp,PMC,,0001388195,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.28
PharMerica Corp,PMC,,0001388195,2012.0,Q1,2012-01-01,2012-03-31,2013-05-01 16:02:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,498900000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q1,2012-01-01,2012-03-31,2013-05-01 16:02:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,498900000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q1,2012-01-01,2012-03-31,2013-05-01 16:02:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,426300000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q1,2012-01-01,2012-03-31,2013-05-01 16:02:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,426300000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q1,2012-01-01,2012-03-31,2013-05-01 16:02:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,72600000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q1,2012-01-01,2012-03-31,2013-05-01 16:02:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,52400000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q1,2012-01-01,2012-03-31,2013-05-01 16:02:25+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2800000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q1,2012-01-01,2012-03-31,2013-05-01 16:02:25+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,5400000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q1,2012-01-01,2012-03-31,2013-05-01 16:02:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,60600000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q1,2012-01-01,2012-03-31,2013-05-01 16:02:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12000000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q1,2012-01-01,2012-03-31,2013-05-01 16:02:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2700000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q1,2012-01-01,2012-03-31,2013-05-01 16:02:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2700000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q1,2012-01-01,2012-03-31,2013-05-01 16:02:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9300000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q1,2012-01-01,2012-03-31,2013-05-01 16:02:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3700000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q1,2012-01-01,2012-03-31,2013-05-01 16:02:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5600000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q1,2012-01-01,2012-03-31,2013-05-01 16:02:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5600000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q1,2012-01-01,2012-03-31,2013-05-01 16:02:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5600000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q1,2012-01-01,2012-03-31,2013-05-01 16:02:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29430190.0
PharMerica Corp,PMC,,0001388195,2012.0,Q1,2012-01-01,2012-03-31,2013-05-01 16:02:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.19
PharMerica Corp,PMC,,0001388195,2012.0,Q1,2012-01-01,2012-03-31,2013-05-01 16:02:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29710150.0
PharMerica Corp,PMC,,0001388195,2012.0,Q1,2012-01-01,2012-03-31,2013-05-01 16:02:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.19
PharMerica Corp,PMC,,0001388195,2012.0,Q1,2012-01-01,2012-03-31,2013-05-01 16:02:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29500000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q1,2012-01-01,2012-03-31,2013-05-01 16:02:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.19
PharMerica Corp,PMC,,0001388195,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 08:02:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,458500000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 08:02:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,458500000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 08:02:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,382600000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 08:02:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,382600000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 08:02:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,75900000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 08:02:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,54900000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 08:02:01+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3000000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 08:02:01+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2800000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 08:02:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,60700000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 08:02:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,15200000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 08:02:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2500000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 08:02:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2500000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 08:02:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12700000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 08:02:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5100000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 08:02:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7600000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 08:02:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7600000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 08:02:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7600000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 08:02:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29489766.0
PharMerica Corp,PMC,,0001388195,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 08:02:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.26
PharMerica Corp,PMC,,0001388195,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 08:02:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29720403.0
PharMerica Corp,PMC,,0001388195,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 08:02:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.26
PharMerica Corp,PMC,,0001388195,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 08:02:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29200000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q2,2012-04-01,2012-06-30,2013-08-02 08:02:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.26
PharMerica Corp,PMC,,0001388195,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 08:03:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,442000000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 08:03:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,442000000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 08:03:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,365900000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 08:03:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,365900000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 08:03:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,76100000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 08:03:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,54500000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 08:03:40+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3200000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 08:03:40+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,6100000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 08:03:40+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
PharMerica Corp,PMC,,0001388195,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 08:03:40+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
PharMerica Corp,PMC,,0001388195,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 08:03:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,63800000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 08:03:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12300000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 08:03:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2400000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 08:03:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2400000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 08:03:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9900000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 08:03:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3900000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 08:03:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6000000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 08:03:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6000000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 08:03:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6000000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 08:03:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29491234.0
PharMerica Corp,PMC,,0001388195,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 08:03:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.2
PharMerica Corp,PMC,,0001388195,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 08:03:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29846679.0
PharMerica Corp,PMC,,0001388195,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 08:03:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.2
PharMerica Corp,PMC,,0001388195,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 08:03:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30000000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q3,2012-07-01,2012-09-30,2013-11-05 08:03:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.2
PharMerica Corp,PMC,,0001388195,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,433200000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,433200000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,357600000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,357600000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,75600000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,52900000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3300000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,5600000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,4500000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,66300000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9300000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2400000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2400000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6900000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3200000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3700000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3700000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3700000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29471734.0
PharMerica Corp,PMC,,0001388195,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.13
PharMerica Corp,PMC,,0001388195,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29901896.0
PharMerica Corp,PMC,,0001388195,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.12
PharMerica Corp,PMC,,0001388195,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29400000.0
PharMerica Corp,PMC,,0001388195,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.13
PharMerica Corp,PMC,,0001388195,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:06:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,439800000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:06:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,439800000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:06:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,355500000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:06:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,355500000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:06:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,84300000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:06:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,56700000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:06:14+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4100000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:06:14+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,3500000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:06:14+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
PharMerica Corp,PMC,,0001388195,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:06:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,64300000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:06:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,20000000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:06:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2600000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:06:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2600000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:06:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,17400000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:06:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6900000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:06:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10500000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:06:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10500000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:06:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10500000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:06:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29566959.0
PharMerica Corp,PMC,,0001388195,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:06:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.36
PharMerica Corp,PMC,,0001388195,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:06:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30063737.0
PharMerica Corp,PMC,,0001388195,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:06:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.35
PharMerica Corp,PMC,,0001388195,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:06:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29200000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:06:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.36
PharMerica Corp,PMC,,0001388195,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 08:01:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,430800000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 08:01:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,430800000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 08:01:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,348200000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 08:01:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,348200000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 08:01:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,82600000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 08:01:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,55500000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 08:01:26+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3900000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 08:01:26+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1900000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 08:01:26+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
PharMerica Corp,PMC,,0001388195,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 08:01:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,61300000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 08:01:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,21300000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 08:01:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2900000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 08:01:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2900000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 08:01:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,18400000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 08:01:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8200000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 08:01:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10200000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 08:01:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10200000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 08:01:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10200000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 08:01:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29713010.0
PharMerica Corp,PMC,,0001388195,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 08:01:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.34
PharMerica Corp,PMC,,0001388195,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 08:01:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30134944.0
PharMerica Corp,PMC,,0001388195,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 08:01:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.34
PharMerica Corp,PMC,,0001388195,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 08:01:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30000000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 08:01:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.34
PharMerica Corp,PMC,,0001388195,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 08:00:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,436800000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 08:00:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,436800000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 08:00:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,357600000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 08:00:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,357600000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 08:00:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,79200000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 08:00:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,55500000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 08:00:57+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3700000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 08:00:57+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,18400000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 08:00:57+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1000000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 08:00:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,78600000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 08:00:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,600000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 08:00:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2600000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 08:00:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2600000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 08:00:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2000000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 08:00:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4200000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 08:00:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6200000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 08:00:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6200000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 08:00:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6200000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 08:00:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29655201.0
PharMerica Corp,PMC,,0001388195,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 08:00:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
PharMerica Corp,PMC,,0001388195,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 08:00:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29655201.0
PharMerica Corp,PMC,,0001388195,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 08:00:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
PharMerica Corp,PMC,,0001388195,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 08:00:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29500000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q3,2013-07-01,2013-09-30,2014-11-06 08:00:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
PharMerica Corp,PMC,,0001388195,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,450500000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,450500000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,369400000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,369400000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,81100000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,57600000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3700000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,3900000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3400000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-1400000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,67200000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13900000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2500000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2500000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11400000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7000000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4400000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4400000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4400000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29601199.0
PharMerica Corp,PMC,,0001388195,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.15
PharMerica Corp,PMC,,0001388195,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30075699.0
PharMerica Corp,PMC,,0001388195,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.15
PharMerica Corp,PMC,,0001388195,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29500000.0
PharMerica Corp,PMC,,0001388195,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.15
PharMerica Corp,PMC,,0001388195,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 08:00:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,452200000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 08:00:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,452200000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 08:00:50+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,372200000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 08:00:50+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,372200000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 08:00:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,80000000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 08:00:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,57200000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 08:00:50+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4400000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 08:00:50+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,6200000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 08:00:50+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1900000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 08:00:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,69700000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 08:00:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10300000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 08:00:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2500000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 08:00:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2500000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 08:00:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7800000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 08:00:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3000000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 08:00:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4800000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 08:00:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4800000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 08:00:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4800000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 08:00:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29753024.0
PharMerica Corp,PMC,,0001388195,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 08:00:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.16
PharMerica Corp,PMC,,0001388195,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 08:00:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30354067.0
PharMerica Corp,PMC,,0001388195,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 08:00:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.16
PharMerica Corp,PMC,,0001388195,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 08:00:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30000000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 08:00:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.16
PharMerica Corp,PMC,,0001388195,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,448600000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,448600000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,366700000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,366700000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,81900000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,57900000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:21+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4300000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:21+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,28200000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:21+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1200000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,91600000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9700000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2300000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2300000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12000000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2300000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9700000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9700000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9700000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30004950.0
PharMerica Corp,PMC,,0001388195,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
PharMerica Corp,PMC,,0001388195,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30004950.0
PharMerica Corp,PMC,,0001388195,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
PharMerica Corp,PMC,,0001388195,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30300000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 08:01:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
PharMerica Corp,PMC,,0001388195,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:00:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,470200000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:00:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,470200000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:00:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,387200000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:00:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,387200000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:00:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,83000000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:00:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,56000000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:00:28+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,4900000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:00:28+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,4900000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:00:28+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,100000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:00:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,65900000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:00:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,17100000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:00:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6400000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:00:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6400000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:00:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10700000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:00:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2200000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:00:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8500000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:00:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8500000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:00:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8500000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:00:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30073133.0
PharMerica Corp,PMC,,0001388195,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:00:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.28
PharMerica Corp,PMC,,0001388195,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:00:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30595302.0
PharMerica Corp,PMC,,0001388195,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:00:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.28
PharMerica Corp,PMC,,0001388195,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:00:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30400000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q3,2014-07-01,2014-09-30,2015-11-06 08:00:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.28
PharMerica Corp,PMC,,0001388195,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,523500000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,523500000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,429100000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,429100000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,94400000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,65200000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,6500000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-2000000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,13700000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-1700000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,81700000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12700000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3000000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3000000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9700000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6500000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3200000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3200000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3200000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29983428.0
PharMerica Corp,PMC,,0001388195,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.11
PharMerica Corp,PMC,,0001388195,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30649131.0
PharMerica Corp,PMC,,0001388195,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.1
PharMerica Corp,PMC,,0001388195,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29600000.0
PharMerica Corp,PMC,,0001388195,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.11
PharMerica Corp,PMC,,0001388195,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:00:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,511600000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:00:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,511600000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:00:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,423000000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:00:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,423000000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:00:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,88600000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:00:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,59000000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:00:34+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,6600000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:00:34+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,6100000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:00:34+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,100000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:00:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,71800000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:00:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,16800000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:00:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1400000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:00:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1400000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:00:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,15400000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:00:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5800000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:00:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9600000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:00:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9600000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:00:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9600000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:00:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30185230.0
PharMerica Corp,PMC,,0001388195,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:00:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.32
PharMerica Corp,PMC,,0001388195,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:00:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30733381.0
PharMerica Corp,PMC,,0001388195,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:00:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.31
PharMerica Corp,PMC,,0001388195,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:00:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30000000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 08:00:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.32
PharMerica Corp,PMC,,0001388195,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 08:02:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,497500000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 08:02:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,497500000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 08:02:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,416300000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 08:02:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,416300000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 08:02:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,81200000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 08:02:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,55400000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 08:02:54+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,7000000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 08:02:54+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,10300000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 08:02:54+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,0.0
PharMerica Corp,PMC,,0001388195,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 08:02:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,72700000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 08:02:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8500000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 08:02:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1900000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 08:02:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1900000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 08:02:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6600000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 08:02:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4300000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 08:02:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2300000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 08:02:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2300000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 08:02:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2300000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 08:02:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30388902.0
PharMerica Corp,PMC,,0001388195,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 08:02:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
PharMerica Corp,PMC,,0001388195,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 08:02:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30829724.0
PharMerica Corp,PMC,,0001388195,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 08:02:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.07
PharMerica Corp,PMC,,0001388195,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 08:02:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28800000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 08:02:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
PharMerica Corp,PMC,,0001388195,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 08:00:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,498800000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 08:00:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,498800000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 08:00:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,420200000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 08:00:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,420200000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 08:00:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,78600000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 08:00:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,52700000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 08:00:26+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,7000000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 08:00:26+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2100000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 08:00:26+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,8200000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 08:00:26+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,100000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 08:00:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,70100000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 08:00:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8500000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 08:00:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2100000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 08:00:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2100000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 08:00:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6400000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 08:00:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3400000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 08:00:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3000000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 08:00:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3000000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 08:00:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3000000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 08:00:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30431845.0
PharMerica Corp,PMC,,0001388195,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 08:00:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.1
PharMerica Corp,PMC,,0001388195,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 08:00:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30896294.0
PharMerica Corp,PMC,,0001388195,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 08:00:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.1
PharMerica Corp,PMC,,0001388195,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 08:00:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30000000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 08:00:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.1
PharMerica Corp,PMC,,0001388195,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,520600000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,520600000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,433900000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,433900000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,86700000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,55400000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,8000000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-5200000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,13500000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-5000000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,66700000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,20000000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1200000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1200000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,18800000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1400000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,20200000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,20200000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,20200000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30363588.0
PharMerica Corp,PMC,,0001388195,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.66
PharMerica Corp,PMC,,0001388195,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30767366.0
PharMerica Corp,PMC,,0001388195,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.66
PharMerica Corp,PMC,,0001388195,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30300000.0
PharMerica Corp,PMC,,0001388195,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.66
PharMerica Corp,PMC,,0001388195,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:01:38+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,524500000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:01:38+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,524500000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:01:38+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,442500000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:01:38+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,442500000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:01:38+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,82000000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:01:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,57000000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:01:38+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,8200000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:01:38+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,3100000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:01:38+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,5800000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:01:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,74100000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:01:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7900000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:01:38+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3000000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:01:38+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3000000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:01:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4900000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:01:38+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,800000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:01:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4100000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:01:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4100000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:01:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4100000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:01:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30527697.0
PharMerica Corp,PMC,,0001388195,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:01:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.13
PharMerica Corp,PMC,,0001388195,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:01:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30917192.0
PharMerica Corp,PMC,,0001388195,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:01:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.13
PharMerica Corp,PMC,,0001388195,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:01:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31500000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 08:01:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.13
PharMerica Corp,PMC,,0001388195,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 07:31:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,519600000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 07:31:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,519600000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 07:31:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,437800000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 07:31:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,437800000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 07:31:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,81800000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 07:31:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,55700000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 07:31:40+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,8200000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 07:31:40+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,4900000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 07:31:40+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,5500000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 07:31:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,74300000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 07:31:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7500000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 07:31:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3300000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 07:31:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3300000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 07:31:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4200000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 07:31:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1700000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 07:31:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2500000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 07:31:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2500000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 07:31:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2500000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 07:31:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30728592.0
PharMerica Corp,PMC,,0001388195,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 07:31:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
PharMerica Corp,PMC,,0001388195,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 07:31:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31028174.0
PharMerica Corp,PMC,,0001388195,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 07:31:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
PharMerica Corp,PMC,,0001388195,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 07:31:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31300000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q2,2016-04-01,2016-06-30,2017-08-02 07:31:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
PharMerica Corp,PMC,,0001388195,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:56:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,512600000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:56:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,512600000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:56:50+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,434100000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:56:50+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,434100000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:56:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,78500000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:56:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,53100000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:56:50+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,8300000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:56:50+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-800000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:56:50+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,5900000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:56:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,66500000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:56:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12000000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:56:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3000000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:56:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3000000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:56:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9000000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:56:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1700000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:56:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7300000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:56:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7300000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:56:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7300000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:56:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30754253.0
PharMerica Corp,PMC,,0001388195,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:56:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.24
PharMerica Corp,PMC,,0001388195,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:56:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31071290.0
PharMerica Corp,PMC,,0001388195,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:56:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.23
PharMerica Corp,PMC,,0001388195,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:56:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30400000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:56:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.24
PharMerica Corp,PMC,,0001388195,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,534400000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,534400000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,450700000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,450700000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,83700000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,54800000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,9000000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2400000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,6500000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,72700000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11000000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,200000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-200000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10800000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3100000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7700000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7700000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7700000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30695411.0
PharMerica Corp,PMC,,0001388195,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.25
PharMerica Corp,PMC,,0001388195,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31157836.0
PharMerica Corp,PMC,,0001388195,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.25
PharMerica Corp,PMC,,0001388195,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,30900000.0
PharMerica Corp,PMC,,0001388195,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.25
PharMerica Corp,PMC,,0001388195,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:01:38+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,566800000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:01:38+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,566800000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:01:38+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,478900000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:01:38+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,478900000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:01:38+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,87900000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:01:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,63500000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:01:38+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,9100000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:01:38+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2600000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:01:38+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3500000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:01:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,78700000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:01:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9200000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:01:38+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3700000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:01:38+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3700000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:01:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5500000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:01:38+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2000000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:01:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3500000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:01:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3500000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:01:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3500000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:01:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30839139.0
PharMerica Corp,PMC,,0001388195,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:01:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.11
PharMerica Corp,PMC,,0001388195,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:01:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31198782.0
PharMerica Corp,PMC,,0001388195,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:01:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
PharMerica Corp,PMC,,0001388195,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:01:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31800000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 08:01:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.11
PharMerica Corp,PMC,,0001388195,2017.0,Q2,2017-04-01,2017-06-30,2017-08-02 07:31:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,592000000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q2,2017-04-01,2017-06-30,2017-08-02 07:31:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,592000000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q2,2017-04-01,2017-06-30,2017-08-02 07:31:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,502400000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q2,2017-04-01,2017-06-30,2017-08-02 07:31:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,502400000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q2,2017-04-01,2017-06-30,2017-08-02 07:31:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,89600000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q2,2017-04-01,2017-06-30,2017-08-02 07:31:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,61800000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q2,2017-04-01,2017-06-30,2017-08-02 07:31:40+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,9900000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q2,2017-04-01,2017-06-30,2017-08-02 07:31:40+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2700000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q2,2017-04-01,2017-06-30,2017-08-02 07:31:40+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3600000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q2,2017-04-01,2017-06-30,2017-08-02 07:31:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,78000000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q2,2017-04-01,2017-06-30,2017-08-02 07:31:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11600000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q2,2017-04-01,2017-06-30,2017-08-02 07:31:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4100000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q2,2017-04-01,2017-06-30,2017-08-02 07:31:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4100000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q2,2017-04-01,2017-06-30,2017-08-02 07:31:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7500000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q2,2017-04-01,2017-06-30,2017-08-02 07:31:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2800000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q2,2017-04-01,2017-06-30,2017-08-02 07:31:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4700000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q2,2017-04-01,2017-06-30,2017-08-02 07:31:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4700000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q2,2017-04-01,2017-06-30,2017-08-02 07:31:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4700000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q2,2017-04-01,2017-06-30,2017-08-02 07:31:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31440495.0
PharMerica Corp,PMC,,0001388195,2017.0,Q2,2017-04-01,2017-06-30,2017-08-02 07:31:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.15
PharMerica Corp,PMC,,0001388195,2017.0,Q2,2017-04-01,2017-06-30,2017-08-02 07:31:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31686524.0
PharMerica Corp,PMC,,0001388195,2017.0,Q2,2017-04-01,2017-06-30,2017-08-02 07:31:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.15
PharMerica Corp,PMC,,0001388195,2017.0,Q2,2017-04-01,2017-06-30,2017-08-02 07:31:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31300000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q2,2017-04-01,2017-06-30,2017-08-02 07:31:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.15
PharMerica Corp,PMC,,0001388195,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 14:56:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,595100000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 14:56:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,595100000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 14:56:50+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,505800000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 14:56:50+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,505800000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 14:56:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,89300000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 14:56:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,62200000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 14:56:50+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,10000000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 14:56:50+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1200000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 14:56:50+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,5700000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 14:56:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,79100000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 14:56:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10200000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 14:56:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4100000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 14:56:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4100000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 14:56:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6100000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 14:56:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2900000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 14:56:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3200000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 14:56:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3200000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 14:56:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3200000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 14:56:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31118756.0
PharMerica Corp,PMC,,0001388195,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 14:56:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.1
PharMerica Corp,PMC,,0001388195,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 14:56:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31401624.0
PharMerica Corp,PMC,,0001388195,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 14:56:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.1
PharMerica Corp,PMC,,0001388195,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 14:56:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32000000.0
PharMerica Corp,PMC,,0001388195,2017.0,Q3,2017-07-01,2017-09-30,2017-11-09 14:56:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.1
